Abstract:Lipid droplets (LDs) with own interface architecture not only play crucial roles in protecting cell from lipotoxicity and lipoapoptosis but also closely relate with many diseases such as fatty liver and diabetes. Thus, as one of important applied biomaterials, fluorescent probes with ultrahigh selectivity for in-situ and high-fidelity imaging LDs in living cells and tissues are critical to elucidate relevant physiological and pathological events as well as detect related diseases. However, available LDs probes only utilizing their waterless neutral cores but ignoring the unique phospholipid monolayer interfaces exhibit low selectivity. Particularly, current probes cannot discriminate neutral cores of LDs from intracellular other lipophilic microenvironments, so that extensively cloud-like background fluorescence diffusing in cytoplasm, which severely limited their applications. Herein, in order to design LDs probes with ultrahigh selectivity, the exceptionally interfacial architecture of LDs is considered adequately and thus an interface-targeting strategy is proposed for the first time. According to the novel strategy, we have developed two amphipathic fluorescent probes (N-Cy and N-Py) by introducing different cations into a lipophilic fluorophore (NBD). Consequently, their cationic moiety precisely locates the interfaces through electrostatic interaction and simultaneously NBD entirely embeds into the waterless core via hydrophobic interaction. Thus high-fidelity and background-free fluorescence imaging of LDs is expectably realized in living cells in-situ. Moreover, LDs in turbid tissues like skeletal muscle slices have been clearly imaged (up to 82 μm depth) in two-photon microscope. Importantly, using N-Cy, we not only intuitively monitored the variations of LDs in number, size and morphology, but also clearly revealed their abnormity in hepatic tissues resulted from fatty liver. Therefore, these unique probes provide excellent imaging tools for elucidating LDs-related physiological and pathological processes, and the interface-targeting strategy possesses universal significance for designing probes with ultrahigh selectivity.

Ultrabright and Highly Polarity‐Sensitive NIR‐I/NIR‐II Fluorophores for the Tracking of Lipid Droplets and Staging of Fatty Liver Disease (adv. Funct. Mater. 12/2022)

Interface-targeting strategy enables two-photon fluorescent lipid droplets probes for high-fidelity imaging turbid tissues and detecting fatty liver.

Engineering of a NIR fluorescent probe for high-fidelity tracking of lipid droplets in living cells and nonalcoholic fatty liver tissues

High-fidelity Imaging of Fatty Liver in Vivo with a Fluorescent and Photoacoustic Dual-Mode Probe by Taking Advantage of the Liver “first Pass Effect”

Novel Strategy for Validating the Existence and Mechanism of the "gut-liver axis" in Vivo by a Hypoxia-Sensitive NIR Fluorescent Probe.

Near-infrared lipid droplets polarity fluorescent probe for early diagnosis of nonalcoholic fatty liver disease

Water-Soluble Lipophilic Near-Infrared Region II Fluorophores for High-Brightness Lipid Layer and Lipid Droplets Imaging Applications

A stable NIR fluorescent probe for imaging lipid droplets in triple-negative breast cancer

pH-triggered hydrophility-adjustable fluorescent probes for simultaneously imaging lipid droplets and lysosomes and the application in fatty liver detection

Bivariate Tracking of NIR Phototherapeutic Probe That Illuminates the Deterioration Process of NAFLD-HCC

Application of a Wash-Free NIR-fluorescent Probe in Detecting the Polarity of Lipid Droplets and Identifying NAFLD

An Ultrasensitive Lipid Droplet-Targeted NIR Emission Fluorescent Probe for Polarity Detection and Its Application in Liver Disease Diagnosis.

Fluorescent Probes with Dual-Targeting Organelles Monitor Polarity in Non-Alcoholic Fatty Liver Disease.

Protein-encapsulated Long-Wavelength Fluorescent Probe Hybrid for Imaging Lipid Droplets in Living Cells and Mice with Non-Alcoholic Fatty Liver

Promoting in Vivo NIR-II Fluorescent Imaging for Lipid in Lipid Metabolism Diseases Diagnosis.

Exploiting the Twisted Intramolecular Charge Transfer Effect to Construct a Wash-Free Solvatochromic Fluorescent Lipid Droplet Probe for Fatty Liver Disease Diagnosis.

Red fluorescent AIE bioprobes with a large Stokes shift for droplet-specific imaging and fatty liver diagnosis

Isophorone-based AIEgens fluorescent probe with red emission for targeting lipid droplets and identifying non-alcoholic fatty liver disease

Rational Design AIE Fluorescent Probes for Wash-Free and Lipid Droplet Specific Imaging of Fatty Liver Based on Coumarin

Trident Anchoring-Lipid Droplets Strategy for Fluorescence/super-Resolution/lifetime Imaging and Diagnosis of Fatty Liver in Vivo

Harnessing polarity-dependent fluorescent probe for lipid droplet metabolism dissection and in vivo nonalcoholic fatty liver disease diagnosis